Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoko Shimada

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Plos One|February 4, 2014
Hypoxia increases gefitinib-resistant lung cancer stem cells through the activation of insulin-like growth factor 1 receptorAkiko Murakami, Fumiyuki Takahashi, Fariz Nurwidya, et al.
BMC Cancer|May 4, 2017
Surfactant protein-D predicts prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer: a case control studyKota Nakamura, Motoyasu Kato, Takehito Shukuya, et al.
Biochemical and Biophysical Research Communications|March 22, 2016
Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cellsIsao Kobayashi, Fumiyuki Takahashi, Fariz Nurwidya, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 28, 2011
Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancerShengri Liao, Bill C Penney, Kristen Wroblewski, et al.
Thoracic Cancer|October 8, 2024
Second malignancy in advanced or recurrent non-small cell lung cancer after the advent of molecular targeted drugs and immunotherapyYoshihiro Masui, Takehito Shukuya, Shunichi Kataoka, et al.
Respirology (Carlton, Vic.)|April 24, 2024
Lymphangioleiomyomatosis as a potent lung cancer risk factor: Insights from a Japanese large cohort studyMasahiro Torasawa, Takehito Shukuya, Kohei Uemura, et al.
Molecular Cancer Research : MCR|October 1, 2021
A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1Aditya Wirawan, Ken Tajima, Fumiyuki Takahashi, et al.
JTO Clinical and Research Reports|July 22, 2024
Trophoblast Cell Surface Antigen 2 Expression in Thymic Carcinoma: Brief ReportKana Kurokawa, Tetsuhiko Asao, Takuo Hayashi, et al.
Drug Design, Development and Therapy|November 5, 2020
Tranilast Inhibits Pulmonary Fibrosis by Suppressing TGFβ/SMAD2 PathwayMotoyasu Kato, Fumiyuki Takahashi, Tadashi Sato, et al.
Biochemistry and Biophysics Reports|September 29, 2017
LSD1/KDM1 isoform LSD1+8a contributes to neural differentiation in small cell lung cancerTakanobu Jotatsu, Shigehiro Yagishita, Ken Tajima, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Plos One|February 4, 2014
Hypoxia increases gefitinib-resistant lung cancer stem cells through the activation of insulin-like growth factor 1 receptorAkiko Murakami, Fumiyuki Takahashi, Fariz Nurwidya, et al.
BMC Cancer|May 4, 2017
Surfactant protein-D predicts prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer: a case control studyKota Nakamura, Motoyasu Kato, Takehito Shukuya, et al.
Biochemical and Biophysical Research Communications|March 22, 2016
Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cellsIsao Kobayashi, Fumiyuki Takahashi, Fariz Nurwidya, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 28, 2011
Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancerShengri Liao, Bill C Penney, Kristen Wroblewski, et al.
Thoracic Cancer|October 8, 2024
Second malignancy in advanced or recurrent non-small cell lung cancer after the advent of molecular targeted drugs and immunotherapyYoshihiro Masui, Takehito Shukuya, Shunichi Kataoka, et al.
Respirology (Carlton, Vic.)|April 24, 2024
Lymphangioleiomyomatosis as a potent lung cancer risk factor: Insights from a Japanese large cohort studyMasahiro Torasawa, Takehito Shukuya, Kohei Uemura, et al.
Molecular Cancer Research : MCR|October 1, 2021
A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1Aditya Wirawan, Ken Tajima, Fumiyuki Takahashi, et al.
JTO Clinical and Research Reports|July 22, 2024
Trophoblast Cell Surface Antigen 2 Expression in Thymic Carcinoma: Brief ReportKana Kurokawa, Tetsuhiko Asao, Takuo Hayashi, et al.
Drug Design, Development and Therapy|November 5, 2020
Tranilast Inhibits Pulmonary Fibrosis by Suppressing TGFβ/SMAD2 PathwayMotoyasu Kato, Fumiyuki Takahashi, Tadashi Sato, et al.
Biochemistry and Biophysics Reports|September 29, 2017
LSD1/KDM1 isoform LSD1+8a contributes to neural differentiation in small cell lung cancerTakanobu Jotatsu, Shigehiro Yagishita, Ken Tajima, et al.
Pageof 6